Evidence map›Paper›PMID 41153744›Full record

ArticleBiomedicines2025

Nanopore Sequencing Reveals Novel Alternative Splice Variants of EZH2 in Pediatric Medulloblastoma.

Josselen Carina Ramírez-Chiquito, Sergio Antony Rosete-Ambriz, Ana Consuelo Olguín-García, María Del Pilar Eguía-Aguilar, Ana Maria Niembro-Zuñiga, Alfonso Marhx-Bracho, Mario Perezpeña-Diazconti, Sergio Juárez-Méndez

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Josselen Carina Ramírez-ChiquitoExperimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
Sergio Antony Rosete-AmbrizExperimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
Ana Consuelo Olguín-GarcíaExperimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.
María Del Pilar Eguía-AguilarExperimental Pathology Research Laboratory, Children's Hospital of Mexico, Federico Gómez, Mexico City 06720, Mexico.ORCID 0000-0003-0385-8902
Ana Maria Niembro-ZuñigaDepartment of Pediatric Oncology, National Institute of Pediatrics, Mexico City 04530, Mexico.
Alfonso Marhx-BrachoDepartment of Surgery, National Institute of Pediatrics, Mexico City 04530, Mexico.
Mario Perezpeña-DiazcontiMolecular Pathology Laboratory, Department of Pathology, National Institute of Pediatrics, Mexico City 04530, Mexico.ORCID 0000-0002-1007-7744
Sergio Juárez-MéndezExperimental Oncology Laboratory, National Institute of Pediatrics, Mexico City 04530, Mexico.ORCID 0000-0002-3269-329X

Funding

E022 Program of the Instituto Nacional de Pediatría protocol 2022/003Federal Funds HIM HIM/2018/092 SSA1555SECIHTI 272633 and CF-2023-G-1007Secretaría de Salud FPIS2024-INP-6405
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

alternative splicingmedulloblastomaONTRNA isoformstranscriptome

Identifiers

PMID41153744
PMCPMC12561525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.